Despite the initial negative impact of the COVID-19 pandemic, the European aesthetic injectable market will expand through 2032. Players in this market will help to support growth through new advancements and differentiated products; the emergence of Asian players with low-cost offerings will also expand the availability of products and make them more affordable for patients. Demand for aesthetic injectables will also be spurred by the rising awareness and acceptability of these procedures, as well as a growing patient pool, including nontraditional patient groups such as men and younger individuals.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for aesthetic injectables in Europe from 2019 through 2032.
New advancements in treatments and products entering the European market will support sales growth.
What new products are entering the market, and how will companies promote adoption of these products?
How do the new products compare to existing ones in the market, and how will they compete against them?
What are the factors that can make a product successful in the aesthetic injectable market?
Despite increasing competitive pressures, large MNCs will continue to dominate the market.
What strategies are established competitors using to maintain their market share?
What are areas that these companies are focusing on going forward?
How will the entrance of newer competitors with low-cost products affect competitive dynamics?
Strategic acquisitions and partnerships help manufacturers expand their product portfolios and customer bases.
What are the notable acquisitions and partnerships that have occurred in this market?
What competitive advantages have these transactions provided to the companies involved?
- Aesthetic Injectables - Market Insights - Europe
- COVID-19 Methodology
- Abstract
- Executive Summary
- Key Report Updates
- Aesthetic Injectable Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Aesthetic Injectable Procedures, by Product Type, Europe, 2019u20132032
- Aesthetic Injectable Procedures, by Country, Europe, 2019u20132032
- Aesthetic Injectable Market, by Product Type, Europe (USD), 2019u20132032
- Aesthetic Injectable Market, by Product Type, Europe (EUR), 2019u20132032
- Aesthetic Injectable Market Growth, by Product Type, Europe, 2020u20132032
- Aesthetic Injectable Market, by Country, Europe (USD, EUR, and GBP), 2019u20132032
- Competitive Insights
- Market Shares
- Market Developments
- Botulinum Toxin Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- BTX Procedures, by Country, Europe, 2019u20132032
- BTX Market, by Country, Europe (USD), 2019u20132032
- BTX Market, by Country, Europe (EUR and GBP), 2019u20132032
- BTX Market Growth, by Country, Europe, 2020u20132032
- Competitive Insights
- Market Shares
- Dermal Filler Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR disclaimer
- Dermal Filler Procedures, by Material, Europe, 2019u20132032
- Dermal Filler Procedures, by Country, Europe, 2019u20132032
- Dermal Filler Market, by Material, Europe (USD and EUR), 2019u20132032
- Dermal Filler Market, by Country, Europe (USD, EUR and GBP), 2019u20132032
- HA
- Non-HA
- Competitive Insights
- Market Shares
- Appendix
Vaidruti Joshi, M.Pharm
Vaidruti Joshi is a research associate on the Orthopedics, Dental and Aesthetics Medtech Insights team at Clarivate, specializing in the field of dental implants. Vaidruti holds a Bachelor’s degree in Pharmacy and a Master’s degree in Pharmacy specializing in Pharmaceutical Analysis from Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Karnataka.